ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Recordati acquires rights to Signifor and osilodrostat from Novartis
July 17, 2019Recordati has agreed to acquire the global rights to two of Novartis’ medicines, Signifor and osilodrostat, for the treatment of patients suffering from endocrine diseases. -
AstraZeneca sells European rights for heart failure treatment for $210M
July 25, 2018Cheplapharm would pay AstraZeneca $200m on completion of the agreement, expected to be finalised in the third quarter of 2018, plus a time-bound payment of $10m and sales-contingent milestones.
Pharma Sources Insight January 2025
